InvestorsHub Logo
Followers 194
Posts 31610
Boards Moderated 2
Alias Born 04/08/2002

Re: None

Tuesday, 06/21/2016 3:18:48 PM

Tuesday, June 21, 2016 3:18:48 PM

Post# of 15820
21-Jun-16 14:59 ET

OPK

Opko Health target raised to $18 at Standpoint Research (9.70 +0.51)
Standpoint Research raises their OPK tgt to $18 from $16. FDA approval on Rayaldee received driving stock higher today (more than 50,000,000 shares short) CEO Frost owns $1.6 bln (33%). If the IBB biotech index ETF was not trading sharply lower again, OPK would probably have crossed $11 on this news. It has been closely tracking the IBB recently. The weakness in OPK was not justified.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News